About Saitama Medical University Hospital
埼玉医科大学病院は、埼玉県入間郡毛呂山町の埼玉医科大学毛呂山キャンパスにある大学病院である。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
8
Pfizer
5
Janssen Research & Development, LLC
3
Bioverativ, a Sanofi company
2
Janssen Pharmaceutical K.K.
2
Amgen
1
AstraZeneca
1
Celgene
1
Eli Lilly and Company
1
Galapagos NV
1
Horizon Therapeutics Ireland DAC
1
Clinical Trials at Saitama Medical University Hospital
During the past decade, Saitama Medical University Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on
average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
2015-11-12
2018-11-28
Completed
580
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
2017-02-28
2025-05-01
Active, not recruiting
2,731
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
2017-11-10
2020-12-14
Completed
272
A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis
2017-11-27
2023-01-25
Completed
444
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)
2018-03-05
2021-10-05
Completed
24
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion
2018-03-17
2021-12-03
Completed
42
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
2018-07-26
2024-03-29
Recruiting
250
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saitama Medical University Hospital" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Pfizer" with 5 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Bioverativ, a Sanofi company" with 2 trials sponsored and "Janssen Pharmaceutical K.K."
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Medical University Hospital"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Saitama Medical University Hospital
According to Clinical.Site data, the most researched conditions in "Saitama Medical University Hospital" are
"Generalized Pustular Psoriasis" (3 trials), "Migraine" (3 trials), "Hemophilia A" (2 trials), "Agglutinin Disease, Cold" (1 trials) and "Alzheimer´s Disease" (1 trials). Many other conditions were trialed in "Saitama Medical University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saitama Medical University Hospital
Most popular intervention types in "Saitama Medical University Hospital" are "Drug" (26 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "BI 685509" (2 trials), "Dexamethasone" (2 trials), "Nintedanib" (2 trials) and "Spesolimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Saitama Medical University Hospital
The vast majority of trials in "Saitama Medical University Hospital" are
26 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Saitama Medical University Hospital
Currently, there are NaN active trials in "Saitama Medical University Hospital".
undefined are not yet recruiting,
12 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Saitama Medical University Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Medical University Hospital, 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".